{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:43Z","timestamp":1792782943013,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mie University","id":[{"id":"https:\/\/ror.org\/01529vy56","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coexistence of anti-neutrophil cytoplasmic antibody -associated glomerulonephritis (ANCA-GN) and membranous nephropathy (MN) is rare. This scoping review mapped evidence on clinicopathologic features, phenotypic heterogeneity, and reporting gaps relevant to future rigorous phenotype-specific comparative studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Comprehensive searches of PubMed, Web of Science, and CENTRAL from inception to April 16, 2026 identified original studies of patients with coexisting ANCA-GN and MN. Two reviewers independently extracted study and participant characteristics, renal and systemic findings, serologic and antigen data, associated conditions, treatments, outcomes, phenotype categories, and temporal relationships. Individual-level cases were assigned using a prespecified phenotype framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy studies (140 patients) were included, comprising 113 individually charted cases and one aggregate-only cohort of 27 patients. Among individual-level cases, median age was 60 years; median serum creatinine, 2.75\u00a0mg\/dL; and median proteinuria, 3.7\u00a0g\/day or g\/g creatinine (g\/gCr). The overlap was phenotypically heterogeneous, including 66 likely myeloperoxidase (MPO)-associated\/ANCA-GN-related cases, 10 likely primary-MN-like overlap cases, 31 secondary\/associated cases, and 6 unclassifiable cases. Temporal relationship was ascertainable for all 113 cases: 101 (89.4%) had concurrent onset (\u2264\u20096 months), 7 (6.2%) had MN preceding ANCA-GN, and 5 (4.4%) had ANCA positivity preceding MN. The evidence base was constrained by case-report predominance, selective antigen testing, sparse longitudinal biomarker\/follow-up data, and nonuniform outcome reporting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Coexisting ANCA-GN and MN is a rare, clinically important, and heterogeneous spectrum rather than a single pooled entity. Future studies should use phenotype-specific designs with standardized antigen testing, crescent reporting, longitudinal ANCA assessment, consistent outcome definitions, and explicit follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-026-02904-y","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:29:00Z","timestamp":1781080140000},"page":"1451-1456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexistence of ANCA-associated glomerulonephritis and membranous nephropathy: a scoping review"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4132-6648","authenticated-orcid":false,"given":"Ryosuke","family":"Saiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"2904_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","volume":"403","author":"A Kronbichler","year":"2024","unstructured":"Kronbichler A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, Stone JH. Diagnosis and management of ANCA-associated vasculitis. Lancet. 2024;403:683\u201398.","journal-title":"Lancet"},{"key":"2904_CR2","doi-asserted-by":"publisher","first-page":"106933","DOI":"10.1016\/j.imlet.2024.106933","volume":"270","author":"M Prendecki","year":"2024","unstructured":"Prendecki M, Gurung A, Pisacano N, Pusey CD. The role of neutrophils in ANCA-associated vasculitis. Immunol Lett. 2024;270:106933.","journal-title":"Immunol Lett"},{"key":"2904_CR3","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. Kidney Int. 2024;105:S71\u2013116.","journal-title":"Kidney Int"},{"key":"2904_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/ajkd.2003.50142","volume":"41","author":"A Vizjak","year":"2003","unstructured":"Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis. 2003;41:539\u201349.","journal-title":"Am J Kidney Dis"},{"key":"2904_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41581-022-00564-1","volume":"18","author":"E Hoxha","year":"2022","unstructured":"Hoxha E, Reinhard L, Stahl RAK. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 2022;18:466\u201378.","journal-title":"Nat Rev Nephrol"},{"key":"2904_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41581-025-00980-z","volume":"21","author":"S Sethi","year":"2025","unstructured":"Sethi S, Fervenza FC. Antigens in membranous nephropathy: discovery and clinical implications. Nat Rev Nephrol. 2025;21:653\u201370.","journal-title":"Nat Rev Nephrol"},{"key":"2904_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.humpath.2010.08.020","volume":"42","author":"K Hanamura","year":"2011","unstructured":"Hanamura K, Tojo A, Kinugasa S, Asaba K, Onozato ML, Uozaki H, et al. Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol. 2011;42:649\u201358.","journal-title":"Hum Pathol"},{"key":"2904_CR8","first-page":"461","volume":"2","author":"K Matsumoto","year":"2009","unstructured":"Matsumoto K, Honda H, Shibata T, Sanada D, Wada Y, Ashikaga E, et al. MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits. NDT Plus. 2009;2:461\u20135.","journal-title":"NDT Plus"},{"key":"2904_CR9","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.ekir.2024.04.041","volume":"9","author":"K Tominaga","year":"2024","unstructured":"Tominaga K, Toda E, Takeuchi K, Takakuma S, Sakamoto E, Kuno H, et al. Myeloperoxidase-associated membranous nephropathy in antineutrophil cytoplasmic antibody-associated glomerulonephritis. Kidney Int Rep. 2024;9:2240\u20139.","journal-title":"Kidney Int Rep"},{"key":"2904_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/XEB.0000000000000277","volume":"19","author":"MDJ Peters","year":"2021","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Implement. 2021;19:3\u201310.","journal-title":"JBI Evid Implement"},{"key":"2904_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373.","journal-title":"Ann Intern Med"},{"key":"2904_CR12","doi-asserted-by":"publisher","first-page":"e1472","DOI":"10.1097\/MD.0000000000001472","volume":"94","author":"R Zou","year":"2015","unstructured":"Zou R, Liu G, Cui Z, Chen M, Zhao MH. Clinical and immunologic characteristics of patients with ANCA-associated glomerulonephritis combined with membranous nephropathy: a retrospective cohort study in a single Chinese center. Med (Baltim). 2015;94:e1472.","journal-title":"Med (Baltim)"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02904-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:51:10Z","timestamp":1789613470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02904-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2904"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02904-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Human and Animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}